Diagnostic quality of Endoscopic Ultrasound-guided Fine Needle Aspiration for Onco-panel for Geneprofiling of pancreatic cancer - Prospective cohort study -

Diagnostic quality of Endoscopic Ultrasound-guided Fine Needle Aspiration for Onco-panel for Geneprofiling of pancreatic cancer - Prospective cohort study - - EUS-FNA for Onco-panel for Geneprofiling

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040099

Enrollment

Registered

2020-04-10

Start date

2020-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with unresectable pancreatic cancer diagnosed by imaging and clinically judged to be eligible for Onco-panel for Geneprofiling during the course of chemotherapy

Exclusion criteria

Exclusion criteria: # Patients who have tendency of bleeding # The lesion cannot be demonstrated # Patients who have the high risk of complication by EUS-FNA # There are some definite vessels between EUS and lesions # The movement by breathing may cause puncture of another organs # Patients who don't understand the aim of this study

Design outcomes

Primary

Measure	Time frame
Diagnostic sensitivity of Onco-panel for Geneprofiling by specimens of EUS-FNA for pancreatic cancer	—

Countries

Japan

Contacts

Public ContactKosuke Takahashi

University of Toyama Third Department of Internal Medicine

takapochi0809@gmail.com076-434-7301

Outcome results